Chordoma / chondrosarcoma | |||||
---|---|---|---|---|---|
Variable | Group 1 | Group 2 | Group 3 | p-value | Combined cohort |
Skull and face | Vertebral column | Sacrum/ coccyx | |||
Total N = 2041 | n = 1214 (69.1%) | n = 297 (16.9%) | n = 246 (14%) | N = 1757 | |
Demographics | |||||
Age | <.0001 | ||||
Mean (SD) | 57.4 (15.8) | 49.5 (17) | 47.9 (17.2) | 54.8 (16.7) | |
Median (IQR) | 58 (49, 69) | 52 (37, 62) | 49 (35, 61) | 56 (45, 65) | |
Range, min-max) | 18–96 | 18–88 | 18–89 | 18–96 | |
Gender: female, n (%) | 519 (42.7%) | 144 (48.4%) | 109 (44.3%) | 0.2018 | 772 (43.9%) |
Insurance | <.0001 | ||||
Commercial, n (%) | 726 (59.8%) | 203 (68.3%) | 181 (73.5%) | 1110 (63.1%) | |
Medicaid, n (%) | 144 (11.8%) | 42 (14.1%) | 30 (12.2%) | 216 (12.2%) | |
Medicare, n (%) | 344 (28.3%) | 52 (17.5%) | 35 (14.2%) | 431 (24.5%) | |
Elixhauser index | 0.054 | ||||
1, n (%) | 415 (34.1%) | 85 (28.6%) | 72 (29.2%) | 0.054 | 572 (32.5%) |
2, n (%) | 468 (38.5%) | 123 (41.4%) | 87 (35.3%) | 678 (38.5%) | |
3+, n (%) | 1214 (17%) | 297 (15.3%) | 246 (14.1%) | 1757 (28%) |